نتائج البحث

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

• Source: A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants

تفاصيل العنوان

Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.

• Authors : Huang J; VIP Department, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/ethnology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology

• Source: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13599-13609. Date of Electronic Publication: 2023 May 15.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria.

• Authors : Yoon JK; Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.; Han DH

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnostic imaging ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/diagnostic imaging

• Source: Cancer research and treatment [Cancer Res Treat] 2023 Jul; Vol. 55 (3), pp. 939-947. Date of Electronic Publication: 2023 Feb 10.Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Diagnostic Performance of LI-RADS v2018 versus KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging with Hepatobiliary Agent: A Systematic Review and Meta-Analysis of Comparative Studies.

• Authors : Shin J; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Lee S

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology; Humans

• Source: Gut and liver [Gut Liver] 2023 May 15; Vol. 17 (3), pp. 466-474. Date of Electronic Publication: 2022 Nov 01.Publisher: Editorial Office of Gut and Liver Country of Publication: Korea (South) NLM ID: 101316452 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Advances in Targeted Immunotherapy for Hepatobiliary Cancers.

• Authors : Ruff SM; Department of Surgery, Division of Surgical Oncology, Wexner Medical Center, The James Comprehensive Cancer Center, The Ohio State University, 395 W. 12th Ave., Suite 670, Columbus, OH 43210, USA.; Shannon AH

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy ; Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/drug therapy

• Source: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 12; Vol. 23 (22). Date of Electronic Publication: 2022 Nov 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

• Authors : The Affiliated Hospital Of Southwest Medical University; Affiliated Hospital of Guangdong Medical University; Huzhou Central Hospital，Affiliated Hospital of Huzhou University

• Source: A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and

تفاصيل العنوان

Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).

• Authors : Tang H; Zhang W ...

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery

• Source: Bioscience trends [Biosci Trends] 2025 Jan 14; Vol. 18 (6), pp. 505-524. Date of Electronic Publication: 2024 Dec 25.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

تفاصيل العنوان

Influence of Three-Dimensional Visual Reconstruction Technology Combined with Virtual Surgical Planning of CTA Images on Precise Resection of Liver Cancer in Hepatobiliary Surgery.

• Authors : Zhao Y; Department of Liver Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.; Chen T

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnostic imaging ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/diagnostic imaging

• Source: Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Jul 07; Vol. 2022, pp. 4376654. Date of Electronic Publication: 2022 Jul 07 (Print Publication:Publisher: Hindawi Country of Publication: United States NLM ID: 101277751 Publication Model: eCollection Cited Medium: Internet ISSN: 1748-6718

تفاصيل العنوان

Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade.

• Authors : Haimerl M; Department of Radiology, University Hospital Regensburg, 93042, Regensburg, Germany.; Utpatel K

Subjects: Biliary Tract Neoplasms/Biliary Tract Neoplasms/Biliary Tract Neoplasms/*pathology ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology ; Contrast Media/Contrast Media/Contrast Media/*metabolism

• Source: Scientific reports [Sci Rep] 2021 Nov 26; Vol. 11 (1), pp. 22991. Date of Electronic Publication: 2021 Nov 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.

• Authors : Park JH; Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea.; Chung YE

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*diagnostic imaging ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*diagnostic imaging; Aged

• Source: PloS one [PLoS One] 2021 Sep 13; Vol. 16 (9), pp. e0257308. Date of Electronic Publication: 2021 Sep 13 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان